MiMedx Group Inc (MDXG)
MiMedx Group Market Cap: 1.144B for May 23, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 22, 2024 | 1.159B |
May 21, 2024 | 1.173B |
May 20, 2024 | 1.181B |
May 17, 2024 | 1.151B |
May 16, 2024 | 1.165B |
May 15, 2024 | 1.193B |
May 14, 2024 | 1.163B |
May 13, 2024 | 1.166B |
May 10, 2024 | 1.100B |
May 09, 2024 | 1.069B |
May 08, 2024 | 1.063B |
May 07, 2024 | 1.076B |
May 06, 2024 | 1.052B |
May 03, 2024 | 1.088B |
May 02, 2024 | 1.107B |
May 01, 2024 | 1.079B |
April 30, 2024 | 909.24M |
April 29, 2024 | 924.00M |
April 26, 2024 | 925.48M |
April 25, 2024 | 921.79M |
April 24, 2024 | 949.09M |
April 23, 2024 | 960.77M |
April 22, 2024 | 938.63M |
April 19, 2024 | 928.30M |
April 18, 2024 | 909.11M |
Date | Value |
---|---|
April 17, 2024 | 934.20M |
April 16, 2024 | 919.44M |
April 15, 2024 | 937.15M |
April 12, 2024 | 950.44M |
April 11, 2024 | 975.52M |
April 10, 2024 | 966.67M |
April 09, 2024 | 1.036B |
April 08, 2024 | 1.018B |
April 05, 2024 | 1.033B |
April 04, 2024 | 1.036B |
April 03, 2024 | 1.034B |
April 02, 2024 | 1.015B |
April 01, 2024 | 1.099B |
March 28, 2024 | 1.132B |
March 27, 2024 | 1.118B |
March 26, 2024 | 1.120B |
March 25, 2024 | 1.151B |
March 22, 2024 | 1.182B |
March 21, 2024 | 1.199B |
March 20, 2024 | 1.205B |
March 19, 2024 | 1.183B |
March 18, 2024 | 1.158B |
March 15, 2024 | 1.158B |
March 14, 2024 | 1.146B |
March 13, 2024 | 1.168B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
TELA Bio Inc | 145.47M |
CEL-SCI Corp | 69.87M |
AIM ImmunoTech Inc | 20.51M |
IGC Pharma Inc | 31.94M |
NovaBay Pharmaceuticals Inc | 4.918M |
Market Cap Related Metrics
PE Ratio | 15.50 |
PS Ratio | 3.078 |
Price to Book Value | 7.346 |
Price to Free Cash Flow | 35.14 |
Price | 7.75 |
Earnings Yield | 6.45% |
Operating PE Ratio | 19.16 |
Normalized PE Ratio | 15.34 |